Detalhe da pesquisa
1.
Gallium-68 labeled somatostatin receptor antagonist PET/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China.
Eur J Nucl Med Mol Imaging
; 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38337073
2.
First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis.
Int J Cancer
; 152(4): 749-760, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36121651
3.
Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma.
Eur J Nucl Med Mol Imaging
; 50(10): 3116-3125, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246998
4.
A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma.
BMC Cancer
; 23(1): 958, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37817078
5.
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib.
Chin J Cancer Res
; 35(5): 526-535, 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37969958
6.
Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Efficacy, and Biomarkers.
Oncologist
; 2022 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445725
7.
A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE.
Eur J Nucl Med Mol Imaging
; 49(5): 1613-1622, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874478
8.
A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma.
BMC Cancer
; 22(1): 197, 2022 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35189839
9.
Evaluation of the diagnostic performance of the EFSUMB CEUS Pancreatic Applications guidelines (2017 version): a retrospective single-center analysis of 455 solid pancreatic masses.
Eur Radiol
; 32(12): 8485-8496, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699767
10.
Synthesis and Evaluation of Bakuchiol Derivatives as Potent Anti-inflammatory Agents in Vitro and in Vivo.
J Nat Prod
; 85(1): 15-24, 2022 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35000392
11.
Combination of 1,8-cineole and beta-caryophyllene synergistically reverses cardiac hypertrophy in isoprenaline-induced mice and H9c2 cells.
Bioorg Chem
; 124: 105823, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489272
12.
Design, synthesis and biological evaluation of novel FAK inhibitors with better selectivity over IR than TAE226.
Bioorg Chem
; 124: 105790, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452915
13.
[Advances in Treatment of Human Epidermal Growth Factor Receptor 2-Positve Gastric Cancer].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 44(5): 899-905, 2022 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-36325789
14.
A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer.
Cancer
; 127(21): 3975-3984, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355801
15.
Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer.
BMC Cancer
; 21(1): 845, 2021 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294055
16.
Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression.
BMC Pulm Med
; 21(1): 282, 2021 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34488711
17.
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 21(11): 1489-1499, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966810
18.
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 21(11): 1500-1512, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966811
19.
The expression of versican and its role in pancreatic neuroendocrine tumors.
Pancreatology
; 20(1): 142-147, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31771905
20.
Metastatic Adrenal Cortical Carcinoma Responding to Octreotide: A Case Report.
Oncologist
; 24(8): e793-e797, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31073023